Published February 2018
| Version v1
Journal article
Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus–Positive Patients With Anal Cancer
Creators
- 1. Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla (United States)
- 2. Center for Translational Radiation Medicine and Imaging, University of California, San Diego, La Jolla (United States)
- 3. Department of Gastroenterology, University of California, San Diego, La Jolla (United States)
- 4. Clinical and Translational Research Institute, University of California, San Diego, La Jolla (United States)
Description
To study the effects of immunosuppression on treatment toxicity, long-term cancer recurrence risk, and survival among human immunodeficiency virus (HIV)-positive anal cancer patients.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2017.09.034Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2017.09.034;
- PII
- S0360301617339342;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 100
- Journal Issue
- 2
- Journal Page Range
- p. 478-485
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54107066
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- AIDS VIRUS; IMMUNOSUPPRESSION; NEOPLASMS; PATIENTS; TOXICITY
- Descriptors DEC
- DISEASES; MICROORGANISMS; PARASITES; VIRUSES
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Inc. All rights reserved.